Literature DB >> 15677756

Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin.

Joseph A Sennello1, Raja Fayad, Alison M Morris, Robert H Eckel, Esra Asilmaz, Jason Montez, Jeffrey M Friedman, Charles A Dinarello, Giamila Fantuzzi.   

Abstract

Concanavalin A-induced hepatotoxicity was compared in lipodystrophic aP2-nSREBP-1c transgenic mice (LD mice) lacking adipose tissue, obese leptin-deficient ob/ob mice, and lean wild-type (WT) mice. Serum leptin and adiponectin were low in LD mice, whereas ob/ob mice had undetectable leptin, but high adiponectin. Protection from hepatotoxicity was observed in ob/ob, but not in LD mice, despite low cytokine levels and reduced T cell activation and hepatic natural killer T cells in both groups. Administration of adiponectin protected LD mice from hepatotoxicity without altering cytokine levels. In contrast, administration of leptin heightened disease susceptibility by restoring cytokine production. Neutralization of TNF alpha protected LD mice from liver damage. Increased in vivo susceptibility to the hepatotoxic effect of TNF alpha was observed in LD mice. In vitro, adiponectin protected primary hepatocytes from TNF alpha-induced death, whereas leptin had no protective effect. In conclusion, although leptin increases susceptibility to hepatotoxicity by regulating cytokine production and T cell activation, adiponectin protects hepatocytes from TNF alpha-induced death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15677756     DOI: 10.1210/en.2004-1572

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  27 in total

1.  In utero undernutrition reduces diabetes incidence in non-obese diabetic mice.

Authors:  A Oge; E Isganaitis; J Jimenez-Chillaron; C Reamer; R Faucette; K Barry; R Przybyla; M E Patti
Journal:  Diabetologia       Date:  2007-03-17       Impact factor: 10.122

2.  Study of adiponectin in chronic liver disease and cholestasis.

Authors:  Tary A Salman; Naglaa Allam; Gasser I Azab; Ahmed A Shaarawy; Mona M Hassouna; Omkolsoum M El-Haddad
Journal:  Hepatol Int       Date:  2010-10-09       Impact factor: 6.047

3.  Adiponectin deficiency exacerbates lipopolysaccharide/D-galactosamine-induced liver injury in mice.

Authors:  Hitoshi Matsumoto; Shinji Tamura; Yoshihiro Kamada; Shinichi Kiso; Juichi Fukushima; Akira Wada; Norikazu Maeda; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa; Iichiro Shimomura; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

Review 4.  Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis.

Authors:  Michał Kukla; Włodzimierz Mazur; Rafał J Bułdak; Krystyna Zwirska-Korczala
Journal:  Mol Med       Date:  2011-07-05       Impact factor: 6.354

Review 5.  Mechanisms of obesity-induced gastrointestinal neoplasia.

Authors:  José O Alemán; Peter R Holt; Leonardo H Eusebi; Luigi Ricciardiello; Kavish Patidar; Arun J Sanyal
Journal:  Gastroenterology       Date:  2013-12-06       Impact factor: 22.682

6.  Role and regulation of adipokines during zymosan-induced peritoneal inflammation in mice.

Authors:  Maria Pini; Melissa E Gove; Joseph A Sennello; Jantine W P M van Baal; Lawrence Chan; Giamila Fantuzzi
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

7.  Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients.

Authors:  L Sieminska; D Niedziolka; A Pillich; B Kos-Kudla; B Marek; M Nowak; H Borgiel-Marek
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

8.  Role of leptin receptor-induced STAT3 signaling in modulation of intestinal and hepatic inflammation in mice.

Authors:  Melissa E Gove; Davina H Rhodes; Maria Pini; Jantine W van Baal; Joseph A Sennello; Raja Fayad; Robert J Cabay; Martin G Myers; Giamila Fantuzzi
Journal:  J Leukoc Biol       Date:  2008-12-03       Impact factor: 4.962

9.  Pathophysiology of NASH: perspectives for a targeted treatment.

Authors:  Fabio Marra; Sophie Lotersztajn
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke.

Authors:  Donal O'Shea; Tom J Cawood; Cliona O'Farrelly; Lydia Lynch
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.